IE
CLYM

Israel Englander’s Climb Bio CLYM Stock Holding History

Israel Englander’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
908,198
-368,062
-29% -$3.8M ﹤0.01% 2115
2026
Q1 		$8.74M Buy
1,276,260
+979,946
+331% +$5.65M ﹤0.01% 2301
2025
Q4 		$1.19M Sell
296,314
-175,390
-37% -$421K ﹤0.01% 4369
2025
Q3 		$948K Sell
471,704
-8,374
-2% -$15.5K ﹤0.01% 4667
2025
Q2 		$595K Buy
480,078
+416,699
+657% +$519K ﹤0.01% 4784
2025
Q1 		$77.3K Buy
+63,379
New +$103K ﹤0.01% 5475
2024
Q4 		– Sell
-111,137
Closed -$566K – 6569
2024
Q3 		$566K Buy
111,137
+99,740
+875% +$706K ﹤0.01% 4730
2024
Q2 		$81K Sell
11,397
-8,709
-43% -$58K ﹤0.01% 5344
2024
Q1 		$55.1K Buy
20,106
+1,683
+9% +$4.63K ﹤0.01% 5673
2023
Q4 		$49.4K Sell
18,423
-39,913
-68% -$104K ﹤0.01% 5478
2023
Q3 		$154K Sell
58,336
-6,595
-10% -$18K ﹤0.01% 5216
2023
Q2 		$182K Sell
64,931
-2,690
-4% -$8.17K ﹤0.01% 5158
2023
Q1 		$196K Sell
67,621
-64
-0.1% -$220 ﹤0.01% 5179
2022
Q4 		$242K Sell
67,685
-4,380
-6% -$13K ﹤0.01% 5222
2022
Q3 		$233K Sell
72,065
-17,879
-20% -$57K ﹤0.01% 5551
2022
Q2 		$272K Buy
+89,944
New +$426K ﹤0.01% 5447
2021
Q4 		– Sell
-71,983
Closed -$1.29M – 7475
2021
Q3 		$1.29M Buy
+71,983
New +$1.49M ﹤0.01% 4402

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's CLYM Position: Q2 2026 in Review

Israel Englander reduced its Climb Bio (CLYM) stake by 29% in Q2 2026, selling an estimated $3.8M and leaving 908,198 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Israel Englander first reported a position in CLYM in Q3 2021 and has held it in 17 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Israel Englander held 908,198 shares of Climb Bio worth $11.8M as of Q2 2026.
  • Israel Englander sold 368,062 Climb Bio shares in Q2 2026, an estimated $3.8M.
  • Climb Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2115 holding.
  • Israel Englander first reported a position in Climb Bio in Q3 2021 and has held it in 17 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.